CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 17 Issue: 1, February 2018

Meet Our Editorial Board Member free to download

Volume:17   Issue: 1
Pp: 1-1
Laszlo Vecsei
DOI: 10.2174/187152731701180426141109
Published on: 26 April, 2018

Preface free to download

Volume:17   Issue: 1
Pp: 2-2
Stephen D. Skaper
DOI: 10.2174/187152731701180426141232
Published on: 26 April, 2018

Commentary: Let the Time Fly: Dopamine is the Arbiter

Volume:17   Issue: 1
Pp: 3-5
Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* and Ti-Fei Yuan*
DOI: 10.2174/1871527316999170505110106
Published on: 05 May, 2017

Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer’s by Genome-wide Association Studies

Volume:17   Issue: 1
Pp: 6-8
A.R. Neelakandan and G.K. Rajanikant*
DOI: 10.2174/1871527317666180213143832
Published on: 13 February, 2018

Antidepressant Potential of Peptides: New Insights as Future Therapeutic

Volume:17   Issue: 1
Pp: 9-13
Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal
DOI: 10.2174/1871527316666170731102237
Published on: 30 July, 2017

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease

Volume:17   Issue: 1
Pp: 14-21
Abdelrahman Ibrahim Abushouk, Ahmed Negida*, Rasha Abdelsalam Elshenawy, Hossam Zein, Ali M. Hammad, Ahmed Menshawy and Wael M.Y. Mohamed
DOI: 10.2174/1871527316666170602101538
Published on: 01 June, 2017

VaD - An Integrated Framework for Cognitive Rehabilitation

Volume:17   Issue: 1
Pp: 22-33
Maria Balea, Dafin Muresanu*, Anton Alvarez, Volker Homberg, Ovidiu Bajenaru, Alla Guekht, Wolf-Dieter Heiss, Livia Popa, Johannes Vester, Ioana Muresanu, Codruta Birle and Dana Slavoaca
DOI: 10.2174/1871527317666180219164545
Published on: 19 February, 2018

Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models

Volume:17   Issue: 1
Pp: 34-42
Ana Carolina Bombardi Duarte, Maycon Giovani Santana, Guilherme di Camilo Orfali, Carlos Tadeu Parisi de Oliveira and Denise Goncalves Priolli*
DOI: 10.2174/1871527317666171221110139
Published on: 20 December, 2017

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

Volume:17   Issue: 1
Pp: 43-53
Lupe C. Espinoza, Marisol Vacacela, Beatriz Clares*, Maria Luisa Garcia, Maria-Jose Fabrega and Ana C. Calpena
DOI: 10.2174/1871527317666180104122347
Published on: 04 January, 2018

In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

Volume:17   Issue: 1
Pp: 54-68
Kanzal Iman, Muhammad Usman Mirza*, Nauman Mazhar, Michiel Vanmeert, Imran Irshad and Mohammad A. Kamal
DOI: 10.2174/1871527317666180115162422
Published on: 15 January, 2018

TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population

Volume:17   Issue: 1
Pp: 69-74
Ada Sandoval-Carrillo, Cosme Alvarado-Esquivel, Carlos Salas-Martinez, Edna M. Mendez-Hernandez, Antonio Sifuentes-Alvarez, Ana L. Martínez-Martinez, Juan M. Castillo-Orona, Jesus Hernandez-Tinoco, Elizabeth I. Antuna-Salcido, Luis F. Sanchez-Anguiano, Lilia M. Velez Velez, Sergio M. Salas-Pacheco, Francisco X. Castellanos-Juarez, Osmel La Llave-Leon, Oscar Arias-Carrion* and Jose M. Salas-Pacheco*
DOI: 10.2174/1871527317666180207165238
Published on: 07 February, 2018